Pharmacological and biochemical characterization of purified A2a adenosine receptors in human platelet membranes by [3H]‐CGS 21680 binding

@article{Varani1996PharmacologicalAB,
  title={Pharmacological and biochemical characterization of purified A2a adenosine receptors in human platelet membranes by [3H]‐CGS 21680 binding},
  author={K. Varani and S. Gessi and A. Dalpiaz and P. Borea},
  journal={British Journal of Pharmacology},
  year={1996},
  volume={117}
}
1 The binding properties of human platelet A2a adenosine receptors, assayed with the A2a‐selective agonist, [3H]‐2‐[p‐(2‐carboxyethyl)‐phenethylamino]‐5′‐N‐ethylcarboxamidoadenosine ([3H]‐CGS 21680), are masked by a non‐receptorial component, the adenotin site. In order to separate A2a receptors from adenotin sites, human platelet membranes were solubilized with 1% 3‐[(3‐cholamidopropyl)dimethylammonio]‐1‐propanesulphonate (CHAPS). The soluble platelet extract was precipitated with polyethylene… Expand
Characterization of A2A adenosine receptors in human lymphocyte membranes by [3H]‐SCH 58261 binding
[3H]‐SCH 58261 labelling of functional A2A adenosine receptors in human neutrophil membranes
Interaction of SSR161421, a novel specific adenosine A(3) receptor antagonist with adenosine A(3) receptor agonists both in vitro and in vivo.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 45 REFERENCES
[3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.
...
1
2
3
4
5
...